GlycoMimetics (GLYC) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Glycomimetics (GLYC) PT Lowered to $15 at Jefferies; Reiterates Buy
November 9, 2017 8:55 AM ESTJefferies lowered its price target on Glycomimetics (NASDAQ: GLYC) to $15.00 (from $16.00) while maintaining a Buy rating following the company's 3Q earnings report and pipeline update. GLYC reported GAAP EPS of ($0.24) vs consensus of ($0.28), reflecting lower R&D costs than previously... More
